⌘K
Loading ticker…
As of 2026-08-24, Elevance Health, Inc. (ELV) has a 3-month relative strength percentile of 53 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47.8 (Neutral). Sector: Financials, ranked 4 of 11. Average daily range 2.7%, relative volume 0.81×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ELV is in a stage 2 uptrend, week 1. Currently in a 29-day base; basing ADR 2.9% (broad 2.7%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 2.0% / 13.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
ELV is held by 2 ETFs as of Jun 2026. Top owner: HWO at 1.62% weight, $15M notional.
Held by 266 ETFs · $10.8B across latest filings · largest weight 4.79% (IHF).
Top 2 by value, from SEC N-PORT-P filings dated Jun 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ELV Jan avg: 2.00% median: 1.63% win: 50% σ: 4.71% n: 4 2022-06-29 → 2026-07-31 | ELV Feb avg: -2.91% median: -2.88% win: 50% σ: 4.51% n: 4 2022-06-29 → 2026-07-31 | ELV Mar avg: 0.61% median: 0.68% win: 50% σ: 7.73% n: 4 2022-06-29 → 2026-07-31 | ELV Apr avg: 7.28% median: 1.93% win: 75% σ: 14.41% n: 4 2022-06-29 → 2026-07-31 | ELV May avg: -1.71% median: -1.29% win: 50% σ: 5.99% n: 4 2022-06-29 → 2026-07-31 | ELV Jun avg: 0.31% median: 0.63% win: 60% σ: 1.50% n: 5 2022-06-29 → 2026-07-31 | ELV Jul avg: -5.37% median: -1.81% win: 20% σ: 12.72% n: 5 2022-06-29 → 2026-07-31 | ELV Aug avg: 3.16% median: 3.18% win: 75% σ: 7.79% n: 4 2022-06-29 → 2026-07-31 (current) | ELV Sep avg: -3.27% median: -3.93% win: 25% σ: 3.91% n: 4 2022-06-29 → 2026-07-31 | ELV Oct avg: -0.01% median: 0.77% win: 50% σ: 17.44% n: 4 2022-06-29 → 2026-07-31 | ELV Nov avg: 2.73% median: 3.41% win: 75% σ: 4.60% n: 4 2022-06-29 → 2026-07-31 | ELV Dec avg: -2.78% median: -2.70% win: 25% σ: 5.37% n: 4 2022-06-29 → 2026-07-31 |